Clinical practice guidelines for management of neuropathic pain: expert panel recommendations for South Africa

References

• Jensen TS, Baron R, Haanpaa M, et al. A new definition of neuropathic pain. Pain 2011; 152: 2204–2205.
   PubMed Web of Science ®Google Scholar
• Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology 2007; 68: 1178–1182.
   PubMed Web of Science ®Google Scholar
• Khenioui H, Cahagne V, Brissot R. Assessment of chronic pain as a disability in patients with spinal cord injuries. Ann Readapt Med Phys 2006; 49: 125–137.
   PubMedGoogle Scholar
• Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 2002; 18: 350–354.
   PubMed Web of Science ®Google Scholar
• Gilron I, Watson CP, Cahill CM, Moulin DE. Neuropathic pain: a practical guide for the clinician. Can Med
   Google Scholar
• Assoc J 2006; 175: 265–275.
   Google Scholar
• Doth AH, Hansson PT, Jensen MP, Taylor RS. The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain 2010; 149: 338–344.
   PubMed Web of Science ®Google Scholar
• Meyer-Rosberg K, Kvarnstrom A, Kinnman E, Gordh T, Nordfors LO, Kristofferson A. Peripheral neuropathic pain—a multidimensional burden for patients. Eur J Pain 2001; 5: 379–389.
   PubMed Web of Science ®Google Scholar
• Cruz-Almeida. Chronicity of pain associated with spinal cord injury: A longitudinal analysis. J Rehabil Res Dev 2005; 42: 585–594.
   PubMed Web of Science ®Google Scholar
• Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 2004; 5: 143–149.
   PubMed Web of Science ®Google Scholar
• O'Connor AB. Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy. Pharmacoeconomics 2009; 27: 95–112.
   PubMed Web of Science ®Google Scholar
• Gore M, Brandenburg NA, Hoffman DL, Tai KS, Stacey B. Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives. J Pain 2006; 7: 892–900.
   PubMed Web of Science ®Google Scholar
• HumanRightsWatch. Global State of Pain Treatment Access to Medicines and Palliative Care, 2011. http://www.hrw.org/reports/2011/06/02/global-state-pain-treatment-0 (accessed 4 October 2011)
   Google Scholar
• Harding R, Powell RA, Kiyange F, Downing J, Mwangi-Powell F. Provision of pain-and symptom-relieving drugs for HIV/AIDS in sub-Saharan Africa. J Pain Symptom Manage 2010; 40: 405–415.
   PubMed Web of Science ®Google Scholar
• Maree JE, Wright SC, Makua MR. The management of HIV- and AIDS-related pain in a primary health clinic in Tshwane, South Africa. Pain Management Nursing 2012 (in press).
   Google Scholar
• Phillips TJ, Cherry CL, Cox S, Marshall SJ, Rice AS. Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials. PLoS One 2010; 5: e14433.
   Web of Science ®Google Scholar
• Martinez V, Attal N, Bouhassira D, Lantéri-Minet M. Chronic neuropathic pain: diagnosis, evaluation and treatment in outpatient services. Guidelines for clinical practice of the French Society for the Study and Treatment of Pain. Douleur et Analgesie 2010; 23: 51–66.
   Google Scholar
• Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010; 150: 573–581.
   PubMed Web of Science ®Google Scholar
• Acevedo JC, Amaya A, Casasola Ode L, et al. Guidelines for the diagnosis and management of neuropathic pain: consensus of a group of Latin American experts. J Pain Palliat Care Pharmacother 2009; 23: 261–281.
   PubMedGoogle Scholar
• Moulin DE, Clark AJ, Gilron I, et al. Pharmacological management of chronic neuropathic pain—consensus statement and guidelines from the Canadian Pain Society. Pain Res Manage 2007; 12: 13–21.
   PubMed Web of Science ®Google Scholar
• Bril V, England JD, Franklin GM, et al. Evidence-based guideline: treatment of painful diabetic neuropathy report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & Rehabilitation. Muscle Nerve 2011; 43: 910–917.
   PubMed Web of Science ®Google Scholar
• Bohlega S, Alsaadi T, Amir A, et al. Guidelines for the pharmacological treatment of peripheral neuropathic pain: expert panel recommendations for the middle East region. J Int Med Res 2010; 38: 295–317.
   PubMed Web of Science ®Google Scholar
• Griene B, Bouajina E, Haddad M, et al. Traitement médicamenteux des douleurs neuropathiques périphériques: recommandations d'un groupe d'experts pour le Maghreb francophone. Douleur et Analgesie 2011; 24: 112–119.
   Web of Science ®Google Scholar
• Gronseth G, Cruccu G, Alksne J, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology
   Google Scholar
• 2008; 71: 1183–1190.
   Google Scholar
• Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004; 63: 959–965.
   PubMed Web of Science ®Google Scholar
• Freeman R, Durso-Decruz E, Emir B. Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses. Diabetes Care 2008; 31: 1448–1454.
   PubMed Web of Science ®Google Scholar
• Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17: 1113-e88.
   Web of Science ®Google Scholar
• Dworkin RH, O'Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010; 85: S3–14.
   PubMed Web of Science ®Google Scholar
• Rowbotham MC, Goli V, Kunz NR, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 2004; 110: 697–706.
   PubMed Web of Science ®Google Scholar
• Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med 2005; 2: e164.
   PubMed Web of Science ®Google Scholar
• Sultan A, Gaskell H, Derry S, Moore RA. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurol 2008; 8: 29.
   PubMed Web of Science ®Google Scholar
• Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy or chronic pain. Cochrane Database Syst Rev 2009: CD007115.
   Google Scholar
• Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev 2009: CD007076.
   Google Scholar
• Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2011: CD007938.
   Google Scholar
• Saarto T, Wiffen PJ. Antidepressants for neuropathic pain: a Cochrane review. J Neurol Neurosurg Psychiatry 2010; 81: 1372–1373.
   PubMed Web of Science ®Google Scholar
• Wiffen P Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev 2005: CD001133.
   Google Scholar
• Wiffen PJ, Derry S, Moore RA. Lamotrigine for acute and chronic pain. Cochrane Database Syst Rev 2011: CD006044.
   Google Scholar
• Wiffen PJ, Derry S, Moore RA, McQuay HJ. Carbamazepine for acute and chronic pain in adults. Cochrane Database Syst Rev 2011: CD005451.
   Google Scholar
• Eisenberg E, McNicol E, Carr DB. Opioids for neuropathic pain. Cochrane Database Syst Rev 2006; 3: CD006146.
   PubMedGoogle Scholar
• Yang M, Zhou M, He L, Chen N, Zakrzewska JM. Non-antiepileptic drugs for trigeminal neuralgia. Cochrane Database Syst Rev 2011: CD004029.
   Google Scholar
• Duhmke RM, Cornblath DD, Hollingshead JR. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2004: CD003726.
   Google Scholar
• Dworkin RH, O'Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence- based recommendations. Pain 2007; 132: 237–251.
   PubMed Web of Science ®Google Scholar
• Torrance BHSN. Epidemiology of neuropathic pain. Pain Management 2011; 1: 87–96.
   PubMedGoogle Scholar
• Ouedraogo DD, Nonguierma V, Napon C, et al. Prevalence of neuropathic pain among black African patients suffering from common low back pain. Rheumatol Int 2011; Apr 28. (Epub ahead of print).
   Google Scholar
• El Sissi W, Arnaout A, Chaarani MW, et al. Prevalence of neuropathic pain among patients with chronic low-back pain in the Arabian Gulf Region assessed using the leeds assessment of neuropathic symptoms and signs pain scale. J Int Med Res 2010; 38: 2135–2145.
   PubMed Web of Science ®Google Scholar
• Atlas ID. Country Summary Table, 2010. http://atlas.idf-bxl.org/ru/node/250. (accessed 20 September 2011).
   Google Scholar
• Rheeder P. Type 2 diabetes: the emerging epidemic. South African Family Practice 2006; 48:20.
   Google Scholar
• Jambart S, Ammache Z, Haddad F, et al. Prevalence of painful diabetic peripheral neuropathy among patients with diabetes mellitus in the Middle East region. J Int Med Res 2011; 39: 366–377.
   PubMed Web of Science ®Google Scholar
• Abbas Z, Archibald L. The diabetic foot in sub-Saharan Africa: A new management paradigm. Diabetic Foot Journal 2007; 10: 128–136.
   Google Scholar
• Levitt NS, Bradshaw D, Zwarenstein MF Bawa AA, Maphumolo S. Audit of public sector primary diabetes care in Cape Town, South Africa: high prevalence of complications, uncontrolled hyperglycaemia, and hypertension. Diabet Med 1997; 14: 1073–1077.
   PubMed Web of Science ®Google Scholar
• UNAIDS. UNAIDS report on the global AIDS epidemic 2010, http://www.unaids.org/globalreport/Global_report.htm (accessed 12 September 2011).
   Google Scholar
• Hitchcock SA, Meyer HP, Gwyther E. Neuropathic pain in AIDS patients prior to antiretroviral therapy. S Afr Med J 2008; 98: 889–892.
   PubMed Web of Science ®Google Scholar
• Wadley AL, Cherry CL, Price P, Kamerman PR. HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans. J Pain Symptom Manage 2011; 41: 700–706.
   PubMed Web of Science ®Google Scholar
• Maritz J, Benatar M, Dave JA, et al. HIV neuropathy in South Africans: frequency, characteristics, and risk factors. Muscle Nerve 2010; 41: 599–606.
   PubMed Web of Science ®Google Scholar
• Narasimooloo C, Naidoo SS, Gaede BM. Adequacy of pain management in HIV-positive patients South African Family Practice 2011; 53: 71–76.
   Google Scholar
• Mphahlele NR, Mitchell D, Kamerman PR. Pain in ambulatory HIV-positive South Africans. Eur J Pain 2012; 16: 447–458.
   PubMed Web of Science ®Google Scholar
• Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 2010; 9: 807–819.
   PubMed Web of Science ®Google Scholar
• Freynhagen R, Bennett MI. Diagnosis and management of neuropathic pain. BMJ 2009; 339: b3002.
   PubMed Web of Science ®Google Scholar
• IASP 2011 update of 1994 Part III: Pain Terms, A Current List with Definitions and Notes on Usage. In: Merskey H, Bogduk N, eds. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. 2nd ed. Seattle: IASP Press; 2011: 209–214.
   Google Scholar
• Haanpaa M, Attal N, Backonja M, et al. NeuPSIG guidelines on neuropathic pain assessment. Pain 2011; 152: 14–27.
   PubMed Web of Science ®Google Scholar
• Cruccu G, Sommer C, Anand P, et al. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol 2010; 17: 1010–1018.
   PubMed Web of Science ®Google Scholar
• Bennett MI, Attal N, Backonja MM, et al. Using screening tools to identify neuropathic pain. Pain 2007; 127: 199–203.
   PubMed Web of Science ®Google Scholar
• Freynhagen R, Baron R, Gockel U, Tolle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006; 22: 1911–1920.
   PubMed Web of Science ®Google Scholar
• Portenoy R. Development and testing of a neuropathic pain screening questionnaire: ID Pain. Curr Med Res Opin 2006; 22:1 555–1565.
   Web of Science ®Google Scholar
• Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005; 114: 29–36.
   PubMed Web of Science ®Google Scholar
• Hansson P, Haanpaa M. Diagnostic work-up of neuropathic pain: computing, using questionnaires or examining the patient? Eur J Pain 2007; 11: 367–369.
   PubMed Web of Science ®Google Scholar
• Attal N. Recent developments in the pharmacological management of neuropathic pain. European Neurological Journal 2010; 2: 25–30.
   Google Scholar
• Wiffen PJ, McQuay HJ, Edwards J, Moore RA. Gabapentin for acute and chronic pain. Cochrane Database of Systematic Reviews 2011: CD005452.
   Google Scholar
• Stacey BR, Barrett JA, Whalen E, Phillips KF, Rowbotham MC. Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief. J Pain 2008; 9: 1006–1017.
   PubMed Web of Science ®Google Scholar
• Pharmaplan (Pty) Ltd. Epleptin (gabapentin) South African Package Insert. October 4, 2005.
   Google Scholar
• Pfizer Laboratories (Pty) Ltd. Lyrica (pregabalin) South African Package Insert. November 30, 2007.
   Google Scholar
• Raskin J, Smith TR, Wong K, et al. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain. J Palliat Med 2006; 9: 29–40.
   PubMed Web of Science ®Google Scholar
• Sindrup SH, Bach FW, Madsen C, Gram LF Jensen TS. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 2003; 60: 1284–1289.
   PubMed Web of Science ®Google Scholar
• Eli Lilly (S.A.) (Pty) Ltd. Cymbalta (duloxetine) South African Package Insert. February 7, 2006.
   Google Scholar
• Wyeth South Africa (Pty) Ltd. Efexor (venlafaxin) South African Package Insert. June 24, 2005.
   Google Scholar
• O'Connor AB, Dworkin RH. Treatment of neuropathic pain: an overview of recent guidelines. Am J Med 2009; 122: S22–32.
   PubMed Web of Science ®Google Scholar
• Fava M, Mulroy R, Alpert J, Nierenberg AA, Rosenbaum JF. Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine. Am J Psychiatry 1997; 154: 1760–1762.
   PubMed Web of Science ®Google Scholar
• Pfizer Laboratories (Pty) Ltd., Norline (Amitriptyline), South African Electronic Package Insert. http://home.intekom.com/pharm/quatrom/noriline.html (accessed 12 September 2011)
   Google Scholar
• QUATROMED Ltd. Noriline (amitriptyline) South African Package Insert. June 10, 1992.
   Google Scholar
• Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005; 118: 289–305.
   PubMed Web of Science ®Google Scholar
• Wu CL, Agarwal S, Tella PK, et al. Morphine versus mexiletine for treatment of postamputation pain: a randomized, placebo-controlled, crossover trial. Anesthesiology 2008; 109: 289–296.
   PubMed Web of Science ®Google Scholar
• Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2002; 59: 1015–1021.
   PubMed Web of Science ®Google Scholar
• Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005; 352: 1324–1334.
   PubMed Web of Science ®Google Scholar
• Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet 2009; 374: 1252–1261.
   PubMed Web of Science ®Google Scholar
• Hanna M, O'Brien C, Wilson MC. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur J Pain 2008; 12: 804–813.
   PubMed Web of Science ®Google Scholar
• Khaliq W, Alam S, Puri N. Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database Syst Rev 2007: CD004846.
   Google Scholar
• Vranken JH, Hollmann MW, van der Vegt MH, et al. Duloxetine in patients with central neuropathic pain caused by spinal cord injury or stroke: a randomized, double-blind, placebo-controlled trial. Pain 2011; 152: 267–273.
   PubMed Web of Science ®Google Scholar
• Turk DC, Audette J, Levy RM, Mackey SC, Stanos S. Assessment and treatment of psychosocial comorbidities in patients with neuropathic pain. Mayo Clin Proc 2010; 85: S42–50.
   PubMed Web of Science ®Google Scholar
• Johnson MI, Bjordal JM. Transcutaneous electrical nerve stimulation for the management of painful conditions: focus on neuropathic pain. Expert Rev Neurother 2011; 11: 735–753.
   PubMed Web of Science ®Google Scholar
• Cruccu G, Aziz TZ, Garcia-Larrea L, et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol 2007; 14: 952–970.
   PubMed Web of Science ®Google Scholar
• Guastella V, Mick G, Laurent B. [Non pharmacologic treatment of neuropathic pain]. Presse Med 2008; 37: 354–347.
   PubMed Web of Science ®Google Scholar
• O'Connell NE, Wand BM, Marston L, Spencer S, Desouza LH. Non-invasive brain stimulation techniques for chronic pain. Cochrane Database Syst Rev 2010: CD008208.
   Google Scholar
• Attal N, Cruccu G, Haanpaa M, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006; 13: 1153–1169.
   PubMed Web of Science ®Google Scholar